Search Tag: HCM

Cardiology Management

2024 22 May

  Despite advances in reducing mortality and hospitalisation rates, individuals living with hypertrophic cardiomyopathy (HCM) often experience compromised quality of life due to symptoms like exertional dyspnoea and reduced exercise capacity. A significant contributor to these challenges in HCM patients is left ventricular outflow tract (LVOT) obstruction,...Read more

Cardiology Management

2019 12 Jun

The American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend that family screening for hypertrophic cardiomyopathy (HCM) should start at the age of 12 years. Screening earlier than this is only recommended in cases with an early growth spurt, family history of sudden cardiac death and prior to competitive sports...Read more